Skip to main content
Top
Literature
1.
go back to reference Krauss GL et al (2018) Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: study 307. Epilepsia 59:866–876CrossRefPubMed Krauss GL et al (2018) Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: study 307. Epilepsia 59:866–876CrossRefPubMed
2.
go back to reference Rektor I et al (2020) Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: analysis of four open-label extension studies. Epilepsia 61:1491–1502CrossRefPubMedPubMedCentral Rektor I et al (2020) Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: analysis of four open-label extension studies. Epilepsia 61:1491–1502CrossRefPubMedPubMedCentral
Metadata
Title
Perampanel-induced erectile dysfunction
Authors
Abhishek Dixit
Anand Kumar
Sameer Trivedi
Deepika Joshi
Publication date
30-11-2023
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 4/2024
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-023-07227-4

Other articles of this Issue 4/2024

Neurological Sciences 4/2024 Go to the issue